LNMGLinike Medical Group Ltd.

About Linike Medical Group Ltd. (LNMG)

Linike Medical Group Ltd. (LNMG) is a Medical Devices company headquartered in Chengdu City, China whose shares trade over-the-counter on the Pink tier.

From 2022, Linike Medical Group Ltd through its British Virgin Islands based subsidiary, China Linike Medical Group Ltd, and China based subsidiaries, Sichuan Huarong Zhengtai Medical Technology Co., Ltd and Chengdu Linike Medical Technology Development Co., Ltd, specialize in the R&D, production, and sales of large-scale external beam therapy equipment-medical electron linear accelerator, used for treating cancers.

Products and services

The company specializes in the R&D, production, and sales of large-scale external beam therapy equipment-medical electron linear accelerator, used for treating cancers.

LNMG key facts

Ticker symbol

LNMG

Market tier

Pink

Sector

Healthcare

Industry

Medical Devices

Headquarters

Chengdu City, China

Country of incorporation

US

Year of incorporation

2011

Employees

53

Estimated market cap

$4.08M (as of Apr 10, 2025)

Shares outstanding

668,948,047

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

10/31

Latest filing

Quarterly Report (Jan 31, 2025)

Linike Medical Group Ltd. leadership

• Jian Wang — Treasurer, CEO, Secretary

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with L